Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM
- PMID: 7958493
- DOI: 10.2337/diab.43.12.1418
Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM
Abstract
To analyze the effects of short-term fasting on postprandial glucose metabolism in non-insulin-dependent diabetes mellitus (NIDDM), two groups of nine obese NIDDM patients and two comparable groups of control subjects underwent a 5-h oral glucose tolerance test after either 14 h or 4 days of fasting. The fluxes and the rates of oxidation and storage of glucose were measured using a dual isotope technique combined with indirect calorimetry. The effect of fasting on insulin action and beta-cell responsiveness was tested in an additional group of six obese NIDDM patients with a euglycemic hyperinsulinemic clamp followed by an intravenous glucagon test. In the diabetic patients, fasting enhanced beta-cell response to glucose and glucagon and did not modify insulin action. This response differs from that of nondiabetic subjects in whom fasting is known to impair insulin secretion and action. Regarding glucose fluxes, it was observed that in the overnight-fasted state, the incremental tissular disposal following glucose ingestion was reduced by approximately 50% in the diabetic versus control subjects in relation to an approximately 62% impairment in glucose storage. After fasting, incremental tissular disposal was restored to normal, glucose oxidation was virtually abolished, and storage was increased approximately threefold. Thus, in NIDDM patients, fasting corrects the defect in glycogen storage without modifying the action of insulin on glucose uptake and improves beta-cell responsiveness, the latter two effects being opposite to those observed in nondiabetic subjects.
Similar articles
-
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.J Clin Endocrinol Metab. 1991 Jan;72(1):96-107. doi: 10.1210/jcem-72-1-96. J Clin Endocrinol Metab. 1991. PMID: 1986032
-
Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.Diabetes. 1996 May;45(5):659-66. doi: 10.2337/diab.45.5.659. Diabetes. 1996. PMID: 8621019 Clinical Trial.
-
Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.Diabetes Care. 1995 May;18(5):666-73. doi: 10.2337/diacare.18.5.666. Diabetes Care. 1995. PMID: 8586004
-
Energy and substrate metabolism in obesity and postobese state.Diabetes Care. 1991 Dec;14(12):1180-8. doi: 10.2337/diacare.14.12.1180. Diabetes Care. 1991. PMID: 1773703 Review.
-
Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds?Aust N Z J Med. 1995 Dec;25(6):870-5. doi: 10.1111/j.1445-5994.1995.tb02894.x. Aust N Z J Med. 1995. PMID: 8770366 Review.
Cited by
-
Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).J Clin Invest. 1996 Jan 1;97(1):180-6. doi: 10.1172/JCI118387. J Clin Invest. 1996. PMID: 8550831 Free PMC article.
-
The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue.J Clin Invest. 1996 Jul 15;98(2):251-5. doi: 10.1172/JCI118786. J Clin Invest. 1996. PMID: 8755631 Free PMC article.
-
Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.Diabetologia. 2009 Jun;52(6):1122-32. doi: 10.1007/s00125-009-1317-8. Epub 2009 Mar 18. Diabetologia. 2009. PMID: 19294363
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical